Literature DB >> 8468470

A protein of the AP-1 family is a component of nuclear factor of activated T cells.

E Castigli1, T A Chatila, R S Geha.   

Abstract

Nuclear factor of activated T cells (NF-AT) is a transcriptional activator involved in the induction of IL-2 gene expression. The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region. The composition of NF-AT protein is still not fully elucidated. We demonstrate that, in normal human T cells, an AP-1 protein is a component of the NF-AT protein complex. This was evidenced by the ability of the AP-1 site to compete with the NF-AT site for binding to NF-AT and by the capacity of immobilized anti-Jun and anti-Fos antibodies to deplete NF-AT-binding activity from nuclear extracts of activated T cells. There was no detectable binding of in vitro translated Jun/Fos heterodimer (AP-1) to the NF-AT sequence, and the NF-AT sequence was unable to inhibit the binding of Jun/Fos to the AP-1 sequence. The presence of an AP-1 protein in the NF-AT protein complex may regulate NF-AT-binding activity through protein-protein interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468470

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  NFAT4 deficiency results in incomplete liver regeneration following partial hepatectomy.

Authors:  Ketsia B Pierre; Christopher M Jones; Janene M Pierce; Ian B Nicoud; T Mark Earl; Ravi S Chari
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

2.  Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.

Authors:  E Parra; M Varga; G Hedlund; T Kalland; M Dohlsten
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor.

Authors:  H Sugawara; M Kurosaki; M Takata; T Kurosaki
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc.

Authors:  S J Szabo; J S Gold; T L Murphy; K M Murphy
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases.

Authors:  H Becker; G Stengl; M Stein; K Federlin
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

6.  Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.

Authors:  R Fuleihan; N Ramesh; A Horner; D Ahern; P J Belshaw; D G Alberg; I Stamenkovic; W Harmon; R S Geha
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

7.  Activation protein 1-dependent transcriptional activation of interleukin 2 gene by Ca2+/calmodulin kinase type IV/Gr.

Authors:  N Ho; M Gullberg; T Chatila
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.